Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

In the Hands of Your Enemy

Author(s):  Worthen Dennis B

Issue:  Nov/Dec 2010 - Volume 14, Number 6
View All Articles in Issue

Page(s):  456-462

In the Hands of Your Enemy Page 1
In the Hands of Your Enemy Page 2
In the Hands of Your Enemy Page 3
In the Hands of Your Enemy Page 4
In the Hands of Your Enemy Page 5
In the Hands of Your Enemy Page 6
In the Hands of Your Enemy Page 7

Download in electronic PDF format for $75

Abstract:  In the days of the post 9/11 attacks in the United States and the response against terrorism, one must question whether the source and supply of medicines in America is safe and adequate. This article reviews a common thread that runs through the periods of national emergency brought on by war, beginning with the Revolutionary War and repeated in the Civil War, World War I, and World War II: access to sufficient safe medicines. The shortage of medicines challenged the birth of the new nation in the Revolutionary War and helped thwart its destruction by the withdrawal of the southern states in the Civil War. Similarly, access to natural medicines and patented synthetic chemicals created major challenges in both World War I and World War II. While not the only factor in victory, medicines did play an important role. Two separate but intertwined questions are evident. The first is whether the United States can control and provide the supply of medicines needed for the health and safety of its citizens—military and civilian. The second is whether the quality, that is the safety and efficacy, can be assured whether the source of the medicine is domestic or imported.

Related Keywords: war, medication shortages, drug supply, foreign sources, drug safety, pharmaceutical quality

Related Categories: HISTORY, QUALITY CONTROL

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
Nov/Dec 2012
Pg. 456-460

In the Hands of Your Enemy
Worthen Dennis B
Nov/Dec 2010
Pg. 456-462

The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
Jul/Aug 2022
Pg. 298-301

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris
, Greeson Nicole MH, Mixon William
Nov/Dec 2020
Pg. 451-458

Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
Mar/Apr 2022
Pg. 100-109

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019
Pg. 467-471

PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
Mar/Apr 2011
Pg. 92

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 294-298

Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
Nov/Dec 2006
Pg. 446-448

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2019
Pg. 387-391

PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 350-351

Documentation: Records and Reports
Akers Michael J
Sep/Oct 2017
Pg. 373-380

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

PreScription: Drug Shortages and Discontinued Drugs
Allen Loyd V Jr
Jul/Aug 2012
Pg. 268

Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
May/Jun 2016
Pg. 202-206

The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase
, Bernard Brian, Cogdill Christopher Blake
Sep/Oct 2015
Pg. 377-380

Standing Together Fixing the Drug Quality and Security Act
Miller David G
Mar/Apr 2015
Pg. 104-106

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Return to Top